Erdheim-Chester disease among neuroinflammatory syndromes: the case for precision medicine

Macarena I de la Fuente1, Marc K Rosenblum1, Eli L Diamond1

  • 1From the Department of Neurology, Sylvester Comprehensive Cancer Center (M.I.d.l.F., A.O.), University of Miami, Miami, FL; and Department of Pathology (M.K.R.), Department of Neurology (E.L.D.), and Department of Neurosurgery (V.S.T.), Memorial Sloan Kettering Cancer Center, New York, NY.

Abstract

No abstract available in PubMed .